The portable MICRO-GC medical device will be used by physicians to detect breath biomarkers indicating various illnesses such as lung cancer, colorectal cancer, and COVID-19
The device separates >100 volatile chemical compounds in a breath in 10 minutes with a sub-ppb (parts-per-billion), thanks to the micro-scale components such as the microfluidic detector.
Device readings are encrypted and sent to our cloud platform where they are analyzed using our proprietary algorithm which has been developed based on machine learning and artificial intelligence to analyze breath patterns revealing diseases and human health conditions. Results are finally relayed back to the device.
The portable Micro-GC medical device will be marketed and sold directly to Physician Offices, Hospitals, Dentists, and Urgent Care Centers. The customer will be able to offer a low cost, non-invasive, early detection screening for multiple maladies, without a lab, in minutes.
The portable Micro-GC medical device can be used in hospitals and at the point-of-care (POC) to provide timely information about disease and health conditions. It can be placed at bedside to analyze breath every 30 minutes, just like an electrocardiogram (ECG) that analyze the heart condition every second.
Given time and resources, we can test for an endless list of diseases and pathogens
